HopeStage
Back to all studies
CompletedNCT01404871

Medication Response Patterns in Obsessive-Compulsive Disorder

About this titleRead the official source — NCT01404871
Medication studyAges 18–65CanadaOCD
The study in practice

Understand this study

Who was this study for?

This study was for people with OCD. Listed age limits: 18 years to 65 years. Other eligibility criteria applied.

Listed locations
Toronto and 1 more locationSee all locations and recruitment

Get this study by email

HopeStage may email me about this study.
Loading the security check...
Study clarity

Study information

Study start dateApril 2009
Recruitment status
Completed
Enrollment listed in the registry
26
Sponsor
Sunnybrook Health Sciences Centre
Sponsor type
Unknown or unclear
Study type
Drug
Intervention type
Drug
Locations
Canada
Age range
From 18 Years to 65 Years
Official registry ID
NCT01404871
Official title
Show the full official title

Predicting Medication Response in Obsessive Compulsive Disorder

Looking for a study you can join?

Explore recruiting studies

Recruitment & locations

Completed

Toronto

Interested in joining this study?

HopeStage may email me about this study.
Loading the security check...
FAQ

Questions about this study

Who is behind this study?

The study sponsor is Sunnybrook Health Sciences Centre.

Did this study involve medication?

Yes. The study involved medication, including clomipramine, escitalopram and duloxetine.

Who was this study for?

This study was for people with OCD. Listed age limits: 18 years to 65 years. Other eligibility criteria applied.

Want to explore more studies?

Explore studies